| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.10M | +75.0K | |
| CEO | 976.1K | $1.35M | +72.7K | |
| Other | 60.0K | $82.8K | - | |
| Other | 46.5K | $64.2K | +2.0K | |
| Dir | 29.8K | $41.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Smith Stan | Director | Buy | 75,000 | $1.34 | $100,200.00 | +5.2% | - | - | |
| Jun 1, 2026 | Gryaznov Sergei | Chief Scientific Officer | Buy | 2,000 | $1.35 | $2,690.00 | +4.5% | - | - | |
| Jun 1, 2026 | Vitoc Vlad | Chief Executive Officer | Buy | 72,700 | $1.39 | $100,885.79 | +8.0% | - | - | |
| Dec 22, 2025 | Smith Stan | Director | Buy | 57,189 | $1.22 | $69,999.34 | +4.2% | +12.0% | - | |
| Dec 22, 2025 | Chaouki Steven M58 | Director | Buy | 40,849 | $1.22 | $49,999.18 | +36.8% | +12.0% | - | |
| Dec 22, 2025 | Louie Ngar Yee52 | Director | Buy | 81,699 | $1.22 | $99,999.58 | +7.0% | +12.0% | - | |
| Dec 5, 2025 | Smith Stan | Director | Buy | 13,740 | $1.20 | $16,440.83 | New | +27.5% | - | |
| Nov 28, 2025 | Vitoc Vlad | Chief Executive Officer | Buy | 72,000 | $1.11 | $79,848.60 | +4.3% | +84.7% | - | |
| Nov 28, 2025 | Luput Cristian | Director | Buy | 38,145 | $1.10 | $41,845.86 | +4.7% | +84.7% | - | |
| Nov 26, 2025 | Smith Stan | Director | Buy | 15,000 | $1.04 | $15,582.00 | +1.1% | +128.3% | - |